The explosion of data being captured by the life science industry during clinical development has made big pharma realize the necessity to re-evaluate the way this data flows through their ...

Data is one of the most valuable resources in today’s global economy—yet the rules that govern it are uneven and not conducive to beneficial cross-border data flows. Four years since former Japanese ...